We help genomics software, sequencing and testing companies move from research into clinical markets and build channels into labs worldwide.
What makes genomics special
Genomics is one of the fastest-moving markets in life sciences. Sequencing costs keep falling, new technologies such as long-read sequencing and multi-omics keep arriving, and the bottleneck has shifted from generating data to interpreting it. Customers range from academic research labs to clinical laboratories, hospitals and pharmaceutical companies, each with very different needs, budgets and buying processes.
The market is also moving from research into routine clinical care. That transition brings bigger opportunities, but also validation requirements, reimbursement questions, data privacy obligations and competition from much larger players.
What commercial success really means
- Crossing from early-adopter research labs into routine clinical use
- Validated workflows that integrate with the lab’s instruments, LIMS and reporting systems
- Recurring revenue that grows with test volume and data, not one-time sales
- Partnerships with instrument vendors, reference labs and distributors that extend your reach
- A clear answer to the “build versus buy” question your customers are asking
- Reimbursement and pricing that support adoption at scale
Understanding the regulatory hurdles
When genomics software and tests are used for clinical decisions, they are often regulated as medical devices. In Europe, the IVDR applies to diagnostic tests and to software that interprets genomic data, which means classification, technical documentation, performance evidence and notified body review. In the U.S., clinical labs operate under CLIA and CAP requirements, and FDA oversight continues to evolve. Patient data is protected by HIPAA, GDPR and similar laws worldwide. A quality system built on ISO 13485 ties it together.
We help genomics companies plan for these requirements early, so regulatory work supports market entry instead of delaying it.
Marketing and sales, AI-enabled
- Technical marketing that speaks to bioinformaticians, lab directors and clinicians alike
- Community building through webinars, user groups and scientific collaborations
- AI to spot labs adopting sequencing from publications, grants and hiring signals
- Personalized, AI-assisted outreach and call preparation for every account
- Product usage analytics to drive renewals, upsell and expansion
- AI-enabled support and onboarding that scale without adding headcount
Ready to talk? Send us an email and we will set up a conversation.